Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$HCTI moving up easy with low float play here
Go $HCTI
$ACW looks good
$SHRK Mergers & Acquisitions Fuel Exploding Social Media Influencers & Branding Opportunities As Multi-Billion Dollar Industry Grows
Source: InvestorsHub NewsWire
Mergers & Acquisitions Fuel Exploding Social Media Influencers & Branding Opportunities As Multi-Billion Dollar Industry Continues to Grow - Company to Acquire Strategic Instagram Partner
Coral Springs, FL -- February 11, 2016 -- InvestorsHub NewsWire -- Social media experts forecast the social media industry to continue to expand at a rapid rate by leveraging influencer & branding platforms to engage and advance the social media experience. Advanced Web/Software Technology & Social Media companies making noise in the market to take note of are SharkReach, Inc. (OTC: SHRK), Twitter Inc. (NYSE: TWTR), Facebook, Inc. (NASDAQ: FB), LinkedIn Corporation (NYSE: LNKD) and Salesforce.com Inc. (NYSE: CRM)
SharkReach, Inc. (OTC: SHRK) reaches agreement to acquire key strategic Instagram Partner with presently projected 2016 Revenues of $1.5 Million. SharkReach, a millennial influence marketing company today announced that it has reached an agreement to acquire 100% of a key strategic partner in the millennial social media marketplace. Under the terms of the agreement, at Closing the Company will acquire 100% of The Mobile Media Lab, LLC for cash and stock in the Company. Closing is scheduled to take place on or before February 28, 2016 but can be extended thirty days by agreement of the parties. Details of the transaction will be released in an upcoming 8K filing.
Read the full SharkReach (SHRK) Press Release at http://www.financialnewsmedia.com/profiles/shrk.html
The Mobile Media Lab focuses on Instagram. In fact, its founders were some of Instagrams earliest adopters: they started the NYC Instagram Meetup Group in March 2011 and were placed on Instagrams Suggested User List shortly thereafter. They turned their passion into The Mobile Media Lab in March of 2012 in order to shape the way brands interact with influencers and their audiences on Instagram. By leveraging personal relationships with hundreds of Instagrammers around the world, their unique approach connects clients with the right Instagrammers for their campaigns. They are the first creative agency to focus on Instagram and have been shaping the way brands advertise with influencers and their audiences on Instagram for nearly 4 years. Instagram is definitely the hottest influencer platform going today, said Jim Louderback, Managing Partner at The Louderback Group and a Member of the Companys Board of Advisors.
In other web application and social media developments and happenings: Twitter (NYSE: TWTR) is tweaking its timeline. The social media site will let people turn on a setting that lets popular tweets related to people you follow show up first in your timeline, followed by the real-time feed most people on Twitter are used to. The new option works similarly to Facebook's (NASDAQ: FB) News Feed in that it uses an algorithm to serve up posts likely to be of interest to you. Facebook has also been making changes to its algorithm recently to try to increase visibility for the posts users want to see most. The new Twitter timeline option is a significant change for the microblogging service, although its existing "while you were away" feature also highlights tweets from the recent past. Read the full article on CBSNews.com
LinkedIn Corporation (NYSE: LNKD), the world's largest professional network on the Internet, earlier this month reported results for the fourth quarter and full year 2015. The transcript with prepared remarks is contained within this press release. In addition, a supplemental presentation will be made available on the investor relations section of the LinkedIn website at investors.linkedin.com. "Q4 was a strong quarter for LinkedIn, bringing to a close a successful year of growth and innovation against our long-term roadmap, said Jeff Weiner, CEO of LinkedIn. We enter 2016 with increased focus on core initiatives that will help drive growth and scale across our portfolio. LNKD closed up yesterday at $101.76 on higher than normal volume exceeding 9Mil shares by the market close.
Salesforce (NYSE: CRM), the Customer Success Platform and world's #1 CRM company, earlier this month introduced the next generation of its Customer Success Platform, Salesforce Lightning, and previewed its product strategy for the first half of its current fiscal year. For 17 years, Salesforce has been raising the bar for CRM. Powered by the latest cloud, social, mobile, data science and IoT technologies, Salesforce has set a rapid pace of innovation with three major releases every yearand this summer, the company will deliver its 50th release. New Salesforce Lightning advancements include Salesforce SteelBrick CPQ, SalesforceIQ Inbox and Field Service Lightning. In addition, Salesforce announced new packaging for Sales Cloud Lightning and Service Cloud Lightning.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand seven hundred dollars for news coverage of the current press release issued by SharkReach, Inc. by a non-affiliated third party. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: (954)345-0611
URL: www.financialnewsmedia.com
Source: FN Media Group
$SHRK Mergers & Acquisitions Fuel Exploding Social Media Influencers & Branding Opportunities As Multi-Billion Dollar Industry Grows
Source: InvestorsHub NewsWire
Mergers & Acquisitions Fuel Exploding Social Media Influencers & Branding Opportunities As Multi-Billion Dollar Industry Continues to Grow - Company to Acquire Strategic Instagram Partner
Coral Springs, FL -- February 11, 2016 -- InvestorsHub NewsWire -- Social media experts forecast the social media industry to continue to expand at a rapid rate by leveraging influencer & branding platforms to engage and advance the social media experience. Advanced Web/Software Technology & Social Media companies making noise in the market to take note of are SharkReach, Inc. (OTC: SHRK), Twitter Inc. (NYSE: TWTR), Facebook, Inc. (NASDAQ: FB), LinkedIn Corporation (NYSE: LNKD) and Salesforce.com Inc. (NYSE: CRM)
SharkReach, Inc. (OTC: SHRK) reaches agreement to acquire key strategic Instagram Partner with presently projected 2016 Revenues of $1.5 Million. SharkReach, a millennial influence marketing company today announced that it has reached an agreement to acquire 100% of a key strategic partner in the millennial social media marketplace. Under the terms of the agreement, at Closing the Company will acquire 100% of The Mobile Media Lab, LLC for cash and stock in the Company. Closing is scheduled to take place on or before February 28, 2016 but can be extended thirty days by agreement of the parties. Details of the transaction will be released in an upcoming 8K filing.
Read the full SharkReach (SHRK) Press Release at http://www.financialnewsmedia.com/profiles/shrk.html
The Mobile Media Lab focuses on Instagram. In fact, its founders were some of Instagrams earliest adopters: they started the NYC Instagram Meetup Group in March 2011 and were placed on Instagrams Suggested User List shortly thereafter. They turned their passion into The Mobile Media Lab in March of 2012 in order to shape the way brands interact with influencers and their audiences on Instagram. By leveraging personal relationships with hundreds of Instagrammers around the world, their unique approach connects clients with the right Instagrammers for their campaigns. They are the first creative agency to focus on Instagram and have been shaping the way brands advertise with influencers and their audiences on Instagram for nearly 4 years. Instagram is definitely the hottest influencer platform going today, said Jim Louderback, Managing Partner at The Louderback Group and a Member of the Companys Board of Advisors.
In other web application and social media developments and happenings: Twitter (NYSE: TWTR) is tweaking its timeline. The social media site will let people turn on a setting that lets popular tweets related to people you follow show up first in your timeline, followed by the real-time feed most people on Twitter are used to. The new option works similarly to Facebook's (NASDAQ: FB) News Feed in that it uses an algorithm to serve up posts likely to be of interest to you. Facebook has also been making changes to its algorithm recently to try to increase visibility for the posts users want to see most. The new Twitter timeline option is a significant change for the microblogging service, although its existing "while you were away" feature also highlights tweets from the recent past. Read the full article on CBSNews.com
LinkedIn Corporation (NYSE: LNKD), the world's largest professional network on the Internet, earlier this month reported results for the fourth quarter and full year 2015. The transcript with prepared remarks is contained within this press release. In addition, a supplemental presentation will be made available on the investor relations section of the LinkedIn website at investors.linkedin.com. "Q4 was a strong quarter for LinkedIn, bringing to a close a successful year of growth and innovation against our long-term roadmap, said Jeff Weiner, CEO of LinkedIn. We enter 2016 with increased focus on core initiatives that will help drive growth and scale across our portfolio. LNKD closed up yesterday at $101.76 on higher than normal volume exceeding 9Mil shares by the market close.
Salesforce (NYSE: CRM), the Customer Success Platform and world's #1 CRM company, earlier this month introduced the next generation of its Customer Success Platform, Salesforce Lightning, and previewed its product strategy for the first half of its current fiscal year. For 17 years, Salesforce has been raising the bar for CRM. Powered by the latest cloud, social, mobile, data science and IoT technologies, Salesforce has set a rapid pace of innovation with three major releases every yearand this summer, the company will deliver its 50th release. New Salesforce Lightning advancements include Salesforce SteelBrick CPQ, SalesforceIQ Inbox and Field Service Lightning. In addition, Salesforce announced new packaging for Sales Cloud Lightning and Service Cloud Lightning.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand seven hundred dollars for news coverage of the current press release issued by SharkReach, Inc. by a non-affiliated third party. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: (954)345-0611
URL: www.financialnewsmedia.com
Source: FN Media Group
$MFST MEDIFIRST SOLUTIONS, INC. ANNOUNCES UPDATE ON FDA SUBMISSION
Source: InvestorsHub NewsWire
Freehold, NJ -- February 11, 2016 -- InvestorsHub NewsWire -- MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the “company” or “Medifirst”) would like to update shareholders on the progress of its 510(k) submission to the Food and Drug Administration (FDA). Commented CEO Bruce J. Schoengood, “We are pleased to inform our shareholders that The Time Machine Infrared Laser System is in the final stages of review for 510(k) approval.” Working with Medifirst’s FDA consulting firm, the company is progressing to gather the information and reports necessary to respond to the request for additional information regarding the hand-held laser system received from the FDA. The deadline for the company to respond is June 2016, but Medifirst anticipates it will have the response completed within the next eight weeks. Upon the completion of the review process to the satisfaction of the FDA, and being awarded 510(k) clearance, Medifirst will begin to sell its laser units across the United States. The company believes that the approval will also jump-start international sales for several distributors in South America and Europe.
Driven by the huge demand for minimally invasive skin and pain treatments, the global market for medical and therapeutic lasers have been estimated to grow as high as to $4 billion in 2015. Continued CEO Schoengood, “This technology represents huge potential growth for the company and we have assembled a team of industry professionals that have assisted in the FDA process. The FDA request for additional information is a common request and we are very excited to complete the process. We appreciate the support and patience of our shareholders and the company will be updating shareholders on company events and progress on a regular basis.” Medifirst believes that the laser devices are very unique and offer an easy-to-use, mobile, affordable and effective product for many different health care professionals.The Time Machine Laser System can serve to enhance their current treatment protocols, as well as produce additional revenue streams from the treatment range Medifirst believes The Time Machine Infrared Laser System is capable of delivering to such health care professionals. Please visit www.medifirstsolutions.com and the Medifirst social media pages for more information.
Contact: Investor Relations
Phone: (732) 786-8044
Email: info@medifirstsolutions.com
Website: www.medifirstsolutions.com
About the Lasers
Medical Lasers Manufacturer, Inc. (“MLM”), a Medifirst subsidiary, will specialize in producing high quality diode-pumped solid-state lasers. The laser division, including products and treatment programs, will be operated out of MLM. The company’s focus is to help patients with specific cosmetic skin conditions, as well as relief of muscle and joint pain and muscle spasm and inflammation. MLM’s manufacturer consists of a group of engineers with decades of experience in laser research and manufacturing that have been providing customized laser products to a wide variety of universities and labs.
About Medifirst Solutions, Inc.
Medifirst Solutions, Inc. is a Nevada corporation that is headquartered in New Jersey. The company seeks innovative medical and healthcare products and technologies which are targeted to both medical and healthcare professionals, as well as everyday consumers. Medifirst is developing and establishing both consumer and professional medical cliental that can serve as a pipeline that will allow for distribution of future products and services. For more details visit www.medifirstsolutions.com for more information.
# # #
Forward-Looking Statements: The statements in this press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control. Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission. Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. We make no commitment to disclose any subsequent revisions to forward-looking statements.
$MFST MEDIFIRST SOLUTIONS, INC. ANNOUNCES UPDATE ON FDA SUBMISSION
Source: InvestorsHub NewsWire
Freehold, NJ -- February 11, 2016 -- InvestorsHub NewsWire -- MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the “company” or “Medifirst”) would like to update shareholders on the progress of its 510(k) submission to the Food and Drug Administration (FDA). Commented CEO Bruce J. Schoengood, “We are pleased to inform our shareholders that The Time Machine Infrared Laser System is in the final stages of review for 510(k) approval.” Working with Medifirst’s FDA consulting firm, the company is progressing to gather the information and reports necessary to respond to the request for additional information regarding the hand-held laser system received from the FDA. The deadline for the company to respond is June 2016, but Medifirst anticipates it will have the response completed within the next eight weeks. Upon the completion of the review process to the satisfaction of the FDA, and being awarded 510(k) clearance, Medifirst will begin to sell its laser units across the United States. The company believes that the approval will also jump-start international sales for several distributors in South America and Europe.
Driven by the huge demand for minimally invasive skin and pain treatments, the global market for medical and therapeutic lasers have been estimated to grow as high as to $4 billion in 2015. Continued CEO Schoengood, “This technology represents huge potential growth for the company and we have assembled a team of industry professionals that have assisted in the FDA process. The FDA request for additional information is a common request and we are very excited to complete the process. We appreciate the support and patience of our shareholders and the company will be updating shareholders on company events and progress on a regular basis.” Medifirst believes that the laser devices are very unique and offer an easy-to-use, mobile, affordable and effective product for many different health care professionals.The Time Machine Laser System can serve to enhance their current treatment protocols, as well as produce additional revenue streams from the treatment range Medifirst believes The Time Machine Infrared Laser System is capable of delivering to such health care professionals. Please visit www.medifirstsolutions.com and the Medifirst social media pages for more information.
Contact: Investor Relations
Phone: (732) 786-8044
Email: info@medifirstsolutions.com
Website: www.medifirstsolutions.com
About the Lasers
Medical Lasers Manufacturer, Inc. (“MLM”), a Medifirst subsidiary, will specialize in producing high quality diode-pumped solid-state lasers. The laser division, including products and treatment programs, will be operated out of MLM. The company’s focus is to help patients with specific cosmetic skin conditions, as well as relief of muscle and joint pain and muscle spasm and inflammation. MLM’s manufacturer consists of a group of engineers with decades of experience in laser research and manufacturing that have been providing customized laser products to a wide variety of universities and labs.
About Medifirst Solutions, Inc.
Medifirst Solutions, Inc. is a Nevada corporation that is headquartered in New Jersey. The company seeks innovative medical and healthcare products and technologies which are targeted to both medical and healthcare professionals, as well as everyday consumers. Medifirst is developing and establishing both consumer and professional medical cliental that can serve as a pipeline that will allow for distribution of future products and services. For more details visit www.medifirstsolutions.com for more information.
# # #
Forward-Looking Statements: The statements in this press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control. Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission. Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. We make no commitment to disclose any subsequent revisions to forward-looking statements.
$FFFC FASTFUNDS FINANCIAL CORPORATION SUBSIDIARY PURE GROW SYSTEMS, LLC PROVIDES UPDATES ON ITS RECENT
Source: InvestorsHub NewsWire
FASTFUNDS FINANCIAL CORPORATION SUBSIDIARY PURE GROW SYSTEMS, LLC PROVIDES UPDATES ON ITS RECENT SHOWING AT THE INDO EXPO IN DENVER, COLORADO AS WIDESPREAD INDUSTRY INTEREST IN ITS PRODUCTS EXCEED COMPANY EXPECTATIONS
WEST PALM BEACH, FL -- February 11, 2016 -- InvestorsHub NewsWire -- FastFunds Financial Corporation (OTCPK: FFFC) (the Company or FastFunds) subsidiary, Pure Grow Systems LLC, is proud to announce the results of its recent participation in the Indo Expo Trade Show held in Denver, Colorado on January 30-31, 2016. This event was held to bring together growers, manufacturers and other trade professionals from throughout the country to share new technologies and information to enhance safety, production and quality within the growing cannabis industry.
"This was a true turning point for Pure Grow Systems and our new grow room cleaning system," stated Russ Mitchell, CEO. "We met with at least 200 growers, distributors and other key professionals in the industry and their reaction to our new system was truly outstanding. This show was our first major grower-oriented event and the reaction from the participants, as well as the organizers, was overwhelmingly positive. Our unique disinfecting system is exactly what the industry has been looking for, especially with the recent recalls related to pesticide use and failures resulting from infected crops not passing key safety tests. We expect to set the new standard for the industry when it comes to safety and quality of these grow operations and the associated processing of the products into the various usable forms."
In addition to the over 20 orders taken at the show, which are now in various stages of finalization regarding input to buyers on shipment instructions, additional product descriptions, and miscellaneous informational requests, Pure Grow Systems expects to ramp up additional distribution channels and maximize direct-sales opportunities over the coming weeks as the follow-up contacts from the event take place. The company also expects to gain positive exposure for the system as a result of the contacts made with key industry advocates and promoters from across the country.
The Company will continue to keep shareholders advised as these important and significant events occur.
About FastFunds Financial Corporation
FastFunds Financial Corporation ("FastFunds" or the "Company") is a holding company that is publicly traded on the OTC Pink exchange, under the symbol "FFFC." Through its wholly-owned subsidiaries, Cannabis Angel, Inc. and The 420 Development Corporation, the Company is focused on acquiring and building a portfolio of revenue producing companies that provide ancillary services to the cannabis industry. FastFunds does not engage in activities that violate Federal laws.
Safe Harbor for Forward-looking Statements
This news release may contain forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the companys progress, business opportunities and growth prospects, they are based on managements current beliefs and assumptions as to future events. However, since the companys operations and business prospects are always subject to risk and uncertainties, the forward-looking events and circumstances discussed in this news release might not occur, and actual results could differ materially from those described, anticipated or implied. For a more complete discussion of such risks and uncertainties, please refer to the company's filings with the Securities and Exchange Commission.
CONTACTS:
FastFunds Financial Corporation
Henry Fong, CEO
561-514-9042
$FFFC FASTFUNDS FINANCIAL CORPORATION SUBSIDIARY PURE GROW SYSTEMS, LLC PROVIDES UPDATES ON ITS RECENT
Source: InvestorsHub NewsWire
FASTFUNDS FINANCIAL CORPORATION SUBSIDIARY PURE GROW SYSTEMS, LLC PROVIDES UPDATES ON ITS RECENT SHOWING AT THE INDO EXPO IN DENVER, COLORADO AS WIDESPREAD INDUSTRY INTEREST IN ITS PRODUCTS EXCEED COMPANY EXPECTATIONS
WEST PALM BEACH, FL -- February 11, 2016 -- InvestorsHub NewsWire -- FastFunds Financial Corporation (OTCPK: FFFC) (the Company or FastFunds) subsidiary, Pure Grow Systems LLC, is proud to announce the results of its recent participation in the Indo Expo Trade Show held in Denver, Colorado on January 30-31, 2016. This event was held to bring together growers, manufacturers and other trade professionals from throughout the country to share new technologies and information to enhance safety, production and quality within the growing cannabis industry.
"This was a true turning point for Pure Grow Systems and our new grow room cleaning system," stated Russ Mitchell, CEO. "We met with at least 200 growers, distributors and other key professionals in the industry and their reaction to our new system was truly outstanding. This show was our first major grower-oriented event and the reaction from the participants, as well as the organizers, was overwhelmingly positive. Our unique disinfecting system is exactly what the industry has been looking for, especially with the recent recalls related to pesticide use and failures resulting from infected crops not passing key safety tests. We expect to set the new standard for the industry when it comes to safety and quality of these grow operations and the associated processing of the products into the various usable forms."
In addition to the over 20 orders taken at the show, which are now in various stages of finalization regarding input to buyers on shipment instructions, additional product descriptions, and miscellaneous informational requests, Pure Grow Systems expects to ramp up additional distribution channels and maximize direct-sales opportunities over the coming weeks as the follow-up contacts from the event take place. The company also expects to gain positive exposure for the system as a result of the contacts made with key industry advocates and promoters from across the country.
The Company will continue to keep shareholders advised as these important and significant events occur.
About FastFunds Financial Corporation
FastFunds Financial Corporation ("FastFunds" or the "Company") is a holding company that is publicly traded on the OTC Pink exchange, under the symbol "FFFC." Through its wholly-owned subsidiaries, Cannabis Angel, Inc. and The 420 Development Corporation, the Company is focused on acquiring and building a portfolio of revenue producing companies that provide ancillary services to the cannabis industry. FastFunds does not engage in activities that violate Federal laws.
Safe Harbor for Forward-looking Statements
This news release may contain forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the companys progress, business opportunities and growth prospects, they are based on managements current beliefs and assumptions as to future events. However, since the companys operations and business prospects are always subject to risk and uncertainties, the forward-looking events and circumstances discussed in this news release might not occur, and actual results could differ materially from those described, anticipated or implied. For a more complete discussion of such risks and uncertainties, please refer to the company's filings with the Securities and Exchange Commission.
CONTACTS:
FastFunds Financial Corporation
Henry Fong, CEO
561-514-9042
$BDIC Blow and Drive Interlock Corporation Announces Production of an Additional One Thousand BDI 747's to Meet High Demand
Source: Marketwired
Blow and Drive Interlock Corporation Announces Production of an Additional One Thousand BDI 747's to Meet High Demand
BEVERLY HILLS, CA-(Marketwired - Feb 11, 2016) - Blow and Drive Interlock Corporation's (OTCQB: BDIC) announces that it has begun its second run on manufacturing for its new state of the art BDI - 747 ignition interlock device (IID). This second run of manufacturing will consist of one thousand (1,000) new BDI 747 IID's. The BDI-747 is the most advanced and user-friendly IID currently on the market in the United States and has already been approved by the National Highway Traffic Safety Administration as well as multiple State agencies.
The first run of manufacturing sold out quicker than expected due to high demand. "Customer's are quickly realizing that Blow & Drive Interlock's product is superior," said Laurence Wainer, CEO of Blow & Drive Interlock. "Every one of the company's first run of units is now on the road with paying clients, with an average contract length of twelve (12) months per client, earning us significant streams of reoccurring revenues."
The first batch of the new one thousand (1,000) BDI-747 have just been delivered to BDIC headquarters and are ready for installation in new client vehicles. The company is forecasting that these new IID units have the potential to generate approximately $1.2 million in gross revenue annually. "Much of this revenue will go straight to the company's bottom line", said Wainer. "The company is already invested in establishing the infrastructure needed to build these units and put them on the road. We are now aggressively executing on our business model."
Blow & Drive Interlock is also currently in advanced discussions with qualified parties to extend the company financing that will allow the company to scale up faster to meet the current market demand. "We are in the final stages of negotiations", said Wainer. "We are examining a couple of different financing options that are currently being extended to the company and we are determining which option will be the most appropriate."
FORWARD-LOOKING DISCLAIMER
This report may contain certain forward-looking statements and information. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Contact Information
Contact:
Blow & Drive Interlock
www.blowanddrive.com
877-238-4492
$BDIC Blow and Drive Interlock Corporation Announces Production of an Additional One Thousand BDI 747's to Meet High Demand
Source: Marketwired
Blow and Drive Interlock Corporation Announces Production of an Additional One Thousand BDI 747's to Meet High Demand
BEVERLY HILLS, CA-(Marketwired - Feb 11, 2016) - Blow and Drive Interlock Corporation's (OTCQB: BDIC) announces that it has begun its second run on manufacturing for its new state of the art BDI - 747 ignition interlock device (IID). This second run of manufacturing will consist of one thousand (1,000) new BDI 747 IID's. The BDI-747 is the most advanced and user-friendly IID currently on the market in the United States and has already been approved by the National Highway Traffic Safety Administration as well as multiple State agencies.
The first run of manufacturing sold out quicker than expected due to high demand. "Customer's are quickly realizing that Blow & Drive Interlock's product is superior," said Laurence Wainer, CEO of Blow & Drive Interlock. "Every one of the company's first run of units is now on the road with paying clients, with an average contract length of twelve (12) months per client, earning us significant streams of reoccurring revenues."
The first batch of the new one thousand (1,000) BDI-747 have just been delivered to BDIC headquarters and are ready for installation in new client vehicles. The company is forecasting that these new IID units have the potential to generate approximately $1.2 million in gross revenue annually. "Much of this revenue will go straight to the company's bottom line", said Wainer. "The company is already invested in establishing the infrastructure needed to build these units and put them on the road. We are now aggressively executing on our business model."
Blow & Drive Interlock is also currently in advanced discussions with qualified parties to extend the company financing that will allow the company to scale up faster to meet the current market demand. "We are in the final stages of negotiations", said Wainer. "We are examining a couple of different financing options that are currently being extended to the company and we are determining which option will be the most appropriate."
FORWARD-LOOKING DISCLAIMER
This report may contain certain forward-looking statements and information. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Contact Information
Contact:
Blow & Drive Interlock
www.blowanddrive.com
877-238-4492
$ILST International Star, Inc. Corporate Update for February 11, 2016
Source: Access Wire
TUCSON, AZ / ACCESSWIRE / February 11, 2016 / International Star, Inc. (OTC: ILST), developer of the Van Deemen Gold project in Northwest Arizona, is pleased to update shareholders as it moves towards completion of its 506 (C) Private Placement ( the "Offering").
The Company is in the midst of numerous discussions/negotiations with potential investors in its 506C. In today's market, the Company does not dictate the terms of capital raising. As such, as we continue to market the Offering, the terms have changed. In fact, we are on our fourth and last iteration of the Private Placement Memorandum and accompanying Exhibits which is 250+ pages and each change needs to be reviewed by our SEC legal counsel.
The terms that are being offered are as follows:
- Amount: Up to $10 million
- Minimum Subscription: $100,000
- Interest: 10% p.a.
- Maturity: 50% Principal Repayment in 42 months. Remaining Principal Repayment in 54 months.
- Incentive Payment: In the event, the average price of gold, as determined by the London Metals Exchange ("LME"), meet or exceed a minimum of $1,200 per troy ounce during a production year, Note Holders will receive from Company, a cash payment ("Gold Payment") dependent on the amount of notes held by each individual investor.
As previously noted, we have a cornerstone investor willing to invest up to $1 million, but is contingent upon commitments from other investors.
This is an enormous undertaking and shareholders and potential investors can see the current Private Placement Memorandum, in its entirety, on our website under the investor menu tab (http://www.ilstholdings.com/investors/private-placement.html).
An escrow account has been set up to receive subscriptions and as funds are received, the Company will provide updates.
Lastly, the Company is in negotiations to participate in a near term mining project, capable of coming on-line within 6 months.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
About International Star: (www.ilstholdings.com)
International Star is a mining Company with claims in the Black Mountains of NW Arizona. Its primary focus is to bring the Van Deemen gold project into production thereby generating cash flow to enable growth and sustainability.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance.
CONTACT:
Michael Shea
International Star, Inc.
Phone: (203) 210-5614
Email: Mshea@ilstholdings.com
www.ilstholdings.com
SOURCE: International Star, Inc.
$ILST International Star, Inc. Corporate Update for February 11, 2016
Source: Access Wire
TUCSON, AZ / ACCESSWIRE / February 11, 2016 / International Star, Inc. (OTC: ILST), developer of the Van Deemen Gold project in Northwest Arizona, is pleased to update shareholders as it moves towards completion of its 506 (C) Private Placement ( the "Offering").
The Company is in the midst of numerous discussions/negotiations with potential investors in its 506C. In today's market, the Company does not dictate the terms of capital raising. As such, as we continue to market the Offering, the terms have changed. In fact, we are on our fourth and last iteration of the Private Placement Memorandum and accompanying Exhibits which is 250+ pages and each change needs to be reviewed by our SEC legal counsel.
The terms that are being offered are as follows:
- Amount: Up to $10 million
- Minimum Subscription: $100,000
- Interest: 10% p.a.
- Maturity: 50% Principal Repayment in 42 months. Remaining Principal Repayment in 54 months.
- Incentive Payment: In the event, the average price of gold, as determined by the London Metals Exchange ("LME"), meet or exceed a minimum of $1,200 per troy ounce during a production year, Note Holders will receive from Company, a cash payment ("Gold Payment") dependent on the amount of notes held by each individual investor.
As previously noted, we have a cornerstone investor willing to invest up to $1 million, but is contingent upon commitments from other investors.
This is an enormous undertaking and shareholders and potential investors can see the current Private Placement Memorandum, in its entirety, on our website under the investor menu tab (http://www.ilstholdings.com/investors/private-placement.html).
An escrow account has been set up to receive subscriptions and as funds are received, the Company will provide updates.
Lastly, the Company is in negotiations to participate in a near term mining project, capable of coming on-line within 6 months.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
About International Star: (www.ilstholdings.com)
International Star is a mining Company with claims in the Black Mountains of NW Arizona. Its primary focus is to bring the Van Deemen gold project into production thereby generating cash flow to enable growth and sustainability.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance.
CONTACT:
Michael Shea
International Star, Inc.
Phone: (203) 210-5614
Email: Mshea@ilstholdings.com
www.ilstholdings.com
SOURCE: International Star, Inc.
$ABOT ABT Reports Success in Beta Testing of its AutoClaim App
Source: InvestorsHub NewsWire
ABT Reports Success in Beta Testing of its AutoClaim App
Pasadena, CA -- February 11, 2016 -- InvestorsHub NewsWire -- ABT Holdings (OTC Pink: “ABOT,” or the “Company”) today announced that it has received positive feedback on beta testing of the “AutoClaim” App Version 4.1 from beta-testers, which included, among several things, benefits and features of the app, desirability to download the app, and end-user experience on the usage of app under normal and stress (during simulated accident scenario) conditions.
The Company is a pioneer in real time Mobile Claims Documentation and Management System and expects to launch the App nationwide by the end of the first quarter of fiscal 2016. The Company is continuously receiving pre-launch awareness as AutoClaim.com is among the premium insurance domain names that generates natural online traffic.
Commenting on the Company’s direction for the launch of AutoClaim App for personal use, Shahan Ohanessian said, “Current test results are clearly showing that the App is delivering the promised user experience with respect to benefits and functionalities. In the next coming weeks, our AutoClaim marketing team will be launching several social media and branding campaigns for a major launch, while the operations team is establishing a solid customer and tech support for our end-users.”
For more details on ABT Holdings, click here.
For more details on AutoClaim App, click here.
For more details on Scoobeez, click here.
For more Company information, click here.
About Scoobeez, subsidiary of ABT Holdings, Inc.
Based in Los Angeles, California, Scoobeez is a “Real Time Delivery” and “Same Day” door to door delivery service company that facilitates same day deliveries for enterprise clients. Scoobeez’s value proposition includes utilization of technologies, exceptional customer experience, and logistic creativity to deliver its clients’ products to their customers within the shortest possible time-frame. For more information, please visit Company’s website by clicking here. You may connect and follow Scoobeez on Facebook, Twitter and Instagram.
About the Company
ABT Holdings, Inc. is a diversified holding company engaged in acquiring, developing and growing various businesses that provide strategic advantages, generate attractive returns and significant free cash flow in order to maximize value of our shareholders.
Safe Harbor / Forward-Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate,” “expect,” and “intend,” among others. These forward-looking statements are based on the Company’s current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our possible need for financing; uncertainties of technological changes; and dependence upon third parties. The Company does not undertake an obligation to update or revise any forward-looking statement. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date hereof.
Company Contact:
Imran Firoz, CFO
ABT Holdings, Inc.
OTC PINK: ABOT
225 S Lake Avenue | Suite 300 | Pasadena | CA 91101
T: +1 818.302.0100
E: ir@abtholdings.com
$ABOT ABT Reports Success in Beta Testing of its AutoClaim App
Source: InvestorsHub NewsWire
ABT Reports Success in Beta Testing of its AutoClaim App
Pasadena, CA -- February 11, 2016 -- InvestorsHub NewsWire -- ABT Holdings (OTC Pink: “ABOT,” or the “Company”) today announced that it has received positive feedback on beta testing of the “AutoClaim” App Version 4.1 from beta-testers, which included, among several things, benefits and features of the app, desirability to download the app, and end-user experience on the usage of app under normal and stress (during simulated accident scenario) conditions.
The Company is a pioneer in real time Mobile Claims Documentation and Management System and expects to launch the App nationwide by the end of the first quarter of fiscal 2016. The Company is continuously receiving pre-launch awareness as AutoClaim.com is among the premium insurance domain names that generates natural online traffic.
Commenting on the Company’s direction for the launch of AutoClaim App for personal use, Shahan Ohanessian said, “Current test results are clearly showing that the App is delivering the promised user experience with respect to benefits and functionalities. In the next coming weeks, our AutoClaim marketing team will be launching several social media and branding campaigns for a major launch, while the operations team is establishing a solid customer and tech support for our end-users.”
For more details on ABT Holdings, click here.
For more details on AutoClaim App, click here.
For more details on Scoobeez, click here.
For more Company information, click here.
About Scoobeez, subsidiary of ABT Holdings, Inc.
Based in Los Angeles, California, Scoobeez is a “Real Time Delivery” and “Same Day” door to door delivery service company that facilitates same day deliveries for enterprise clients. Scoobeez’s value proposition includes utilization of technologies, exceptional customer experience, and logistic creativity to deliver its clients’ products to their customers within the shortest possible time-frame. For more information, please visit Company’s website by clicking here. You may connect and follow Scoobeez on Facebook, Twitter and Instagram.
About the Company
ABT Holdings, Inc. is a diversified holding company engaged in acquiring, developing and growing various businesses that provide strategic advantages, generate attractive returns and significant free cash flow in order to maximize value of our shareholders.
Safe Harbor / Forward-Looking Statements
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate,” “expect,” and “intend,” among others. These forward-looking statements are based on the Company’s current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our possible need for financing; uncertainties of technological changes; and dependence upon third parties. The Company does not undertake an obligation to update or revise any forward-looking statement. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements. The information set forth herein speaks only as of the date hereof.
Company Contact:
Imran Firoz, CFO
ABT Holdings, Inc.
OTC PINK: ABOT
225 S Lake Avenue | Suite 300 | Pasadena | CA 91101
T: +1 818.302.0100
E: ir@abtholdings.com
$TSGL The Staffing Group to Acquire North Dakota Industrial Staffing Firm
Source: InvestorsHub NewsWire
The Staffing Group to Acquire North Dakota Industrial Staffing Firm
Company Plans Industry Roll-up
Atlanta, GA, United States, via NZINET CORP., 02/11/2016 - - The Staffing Group, Ltd. (OTC PINK: TSGL) (the "Company"), today announced it plans to acquire a North Dakota industrial staffing firm.
With three locations operating in North Dakota, the acquisition target provides skilled personnel to various industries including trucking, manufacturing, construction, and the oil and gas industry in the Bakken Shale Region.
The proposed transaction is expected to add as much as $6 million in revenue to the Company in 2016 and in excess of $8.5 million in 2017. Definitive terms are being finalized and the Company expects to close on the acquisition upon a successful completion of its equity raise. On February 4, 2016, the Company filed a Form D with the U.S. Securities and Exchange Commission, stating its intention to raise $5 million in a non-brokered private placement.
After divesting underperforming assets and a swift clean-up of its balance sheet at the end of 2015, the Company is now focused on executing an aggressive buy-and-build strategy through the acquisition and integration of small to medium sized staffing businesses with focus on the light industrial, engineering, manufacturing and construction staffing space. The Company believes the light industrial staffing segment is ripe for consolidation and will seek accretive acquisitions that will drive annual revenues to $75 million within the next 36 months.
Safe Harbor Statement
This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of The Staffing Group, Ltd.., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may", "would", "will", "expect", "estimate", "can", "believe", "potential", and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond The Staffing Group, Ltd.'s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in The Staffing Group, Ltd.'s filings with the U.S. Securities and Exchange Commission.
Contact Information
Contact Information
The Staffing Group, Ltd.
Kim Thompson
678-881-0834
kthompson@staffinggroupltd.com
$TSGL The Staffing Group to Acquire North Dakota Industrial Staffing Firm
Source: InvestorsHub NewsWire
The Staffing Group to Acquire North Dakota Industrial Staffing Firm
Company Plans Industry Roll-up
Atlanta, GA, United States, via NZINET CORP., 02/11/2016 - - The Staffing Group, Ltd. (OTC PINK: TSGL) (the "Company"), today announced it plans to acquire a North Dakota industrial staffing firm.
With three locations operating in North Dakota, the acquisition target provides skilled personnel to various industries including trucking, manufacturing, construction, and the oil and gas industry in the Bakken Shale Region.
The proposed transaction is expected to add as much as $6 million in revenue to the Company in 2016 and in excess of $8.5 million in 2017. Definitive terms are being finalized and the Company expects to close on the acquisition upon a successful completion of its equity raise. On February 4, 2016, the Company filed a Form D with the U.S. Securities and Exchange Commission, stating its intention to raise $5 million in a non-brokered private placement.
After divesting underperforming assets and a swift clean-up of its balance sheet at the end of 2015, the Company is now focused on executing an aggressive buy-and-build strategy through the acquisition and integration of small to medium sized staffing businesses with focus on the light industrial, engineering, manufacturing and construction staffing space. The Company believes the light industrial staffing segment is ripe for consolidation and will seek accretive acquisitions that will drive annual revenues to $75 million within the next 36 months.
Safe Harbor Statement
This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of The Staffing Group, Ltd.., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may", "would", "will", "expect", "estimate", "can", "believe", "potential", and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond The Staffing Group, Ltd.'s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in The Staffing Group, Ltd.'s filings with the U.S. Securities and Exchange Commission.
Contact Information
Contact Information
The Staffing Group, Ltd.
Kim Thompson
678-881-0834
kthompson@staffinggroupltd.com
$JNSH JNS Holdings Increases its Authorized Shares of Common Stock
Source: InvestorsHub NewsWire
JNS Holdings Increases its Authorized Shares of Common Stock
Wheeling, IL -- February 11, 2016 -- InvestorsHub NewsWire -- JNS Holdings (OTC: JNSH) today announced it has approved an amendment to its Certificate of Incorporation to increase the number of authorized shares of JNS Holdings common stock from 200,000,000 to 300,000,000. The company stated that the increase in authorized shares is intended to restore our flexibility to position JNS Holdings for future growth.
JNS Holdings has and always will operate in an extremely conservative manor and believes that it is prudent to increase the authorized number of shares of common stock to meet business needs, such as upgrading our owned and operated EV charging network and or any equity offering, promptly as they arise.
Brian Howe President & CEO stated, The company anticipates that the increase of our authorized common shares will make its stock more accessible to investors, enhance liquidity for shareholders, and further enhance growth.
About JNS Holdings Corporation:
JNS Holdings focuses on building solid growth for our investors and shareholders through expansion of our core businesses and subsidiaries, see (www.jnsholdings.com) while seeking additional strategic opportunities. JNS Power & Evolve USA Charging Corporation is the Chicago (IL) based subsidiaries of JNS Holdings specializing in EV infrastructure solutions. JNS is committed in creating a useful and well maintained network for EV charging. The corporate headquarters is located in Wheeling, Illinois. Connect with JNSH on Facebook or Twitter.
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no
obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contacts
JNS Holdings Corporation
Brian Howe CEO
www.jnsholdings.com
info@jnsholdings.com
(847) 520-2899
$JNSH JNS Holdings Increases its Authorized Shares of Common Stock
Source: InvestorsHub NewsWire
JNS Holdings Increases its Authorized Shares of Common Stock
Wheeling, IL -- February 11, 2016 -- InvestorsHub NewsWire -- JNS Holdings (OTC: JNSH) today announced it has approved an amendment to its Certificate of Incorporation to increase the number of authorized shares of JNS Holdings common stock from 200,000,000 to 300,000,000. The company stated that the increase in authorized shares is intended to restore our flexibility to position JNS Holdings for future growth.
JNS Holdings has and always will operate in an extremely conservative manor and believes that it is prudent to increase the authorized number of shares of common stock to meet business needs, such as upgrading our owned and operated EV charging network and or any equity offering, promptly as they arise.
Brian Howe President & CEO stated, The company anticipates that the increase of our authorized common shares will make its stock more accessible to investors, enhance liquidity for shareholders, and further enhance growth.
About JNS Holdings Corporation:
JNS Holdings focuses on building solid growth for our investors and shareholders through expansion of our core businesses and subsidiaries, see (www.jnsholdings.com) while seeking additional strategic opportunities. JNS Power & Evolve USA Charging Corporation is the Chicago (IL) based subsidiaries of JNS Holdings specializing in EV infrastructure solutions. JNS is committed in creating a useful and well maintained network for EV charging. The corporate headquarters is located in Wheeling, Illinois. Connect with JNSH on Facebook or Twitter.
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no
obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.
Contacts
JNS Holdings Corporation
Brian Howe CEO
www.jnsholdings.com
info@jnsholdings.com
(847) 520-2899
$PSID Biotech & Medical Device Companies Make Significant Sales Growth Progress with Advanced Healthcare Products Fueling New
Source: InvestorsHub NewsWire
Biotech & Medical Device Companies Make Significant Sales Growth Progress with Advanced Healthcare Products Fueling New Distributor Opportunities
Coral Springs, FL (February 11, 2016) -- Industry experts forecast continued growth for the biotech - healthcare products industry, especially for medical device market projected to reach new levels as innovative applications & technologies move sector forward. Healthcare services and medical device product companies with recent developments of importance in the markets are PositiveID Corporation (OTC: PSID), Electromed, Inc. (NYSE: ELMD), DexCom, Inc. (NASDAQ: DXCM), Boston Scientific Corporation (NYSE: BSX) and ResMed Inc. (NYSE: RMD)
PositiveID Corporation (OTCQB: PSID), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics subsidiary, which markets the Caregiver FDA-cleared non-contact thermometer, made significant progress on its growth plan in January 2016, including entering into agreements with five new healthcare products distributors, increasing sequential monthly sales growth, and establishing several near-term pipeline opportunities. Thermomedics Caregiver thermometer is targeting the fastest growing segment of the global temperature monitoring device market, estimated at $1 billion by 2020. Caregiver is a clinical grade, infrared thermometer for measurement of forehead temperature in adults, children, and infants, without contact. It delivers an oral-equivalent temperature directly from the forehead in 1-2 seconds. Since there is no skin contact and Caregiver does not require probe cover supplies, it reduces the risk of cross-contamination, which is an increasing concern, and saves healthcare facilities the cost of covers (as much as $0.05 to $0.10 per temperature), storage space, and waste disposal costs.
Read the full PositiveID (PSID) Press Release at http://www.financialnewsmedia.com/profiles/psid.html
It is estimated that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone. Other methods of clinical thermometry, which include predictive oral/rectal/axillary electronic, infrared tympanic, temporal artery contact scanner, etc., may require expensive protective probe covers, intensive technique concentration, which make them prone to mistaken placement or dwell time, and many have the potential to need replacement metal probes, cords, or other parts. January 2016 was the first full month of Thermomedics operations under PositiveIDs management control, stated William J. Caragol, Chairman and CEO of PositiveID. We already see that by better capitalizing the business, entering into new distribution agreements, managing inventory, and planning for the future, we can generate immediate results in this business operationally and financially.
In other Healthcare Services & Products news and developments: Electromed, Inc. (NYSE: ELMD) this week announced financial results for the three- and six-month periods ended December 31, 2015. Net revenues for the second quarter of fiscal 2016 were $6.26 million, a 28.3% or $1.38 million increase, compared to the second quarter of fiscal 2015. Growth in total net revenues was attributable to strong results in the home care market in which revenue increased by 21.5%, or $0.97 million, compared to the same period of fiscal 2015. Home care sales, which accounted for nearly 88% of revenues, increased due to a higher number of approvals, a higher conversion rate of referrals to approvals, and a higher average selling price from third party payers, such as insurance companies, Medicare and Medicaid, for the Companys SmartVest products.
DexCom, Inc. (NASDAQ: DXCM), developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital, this week announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Leerink Partners 5th Annual Global Healthcare Conference in New York City, New York on Thursday, February 11, 2016 at 3:05pm (EST). The presentation, which will occur live at the Waldorf Astoria Hotel, will be concurrently webcast. The link to the webcast will be available on the DexCom website at www.dexcom.com by navigating to Our Company, then Investor Relations, and finally Events and Webcasts and will be archived there for future reference.
Boston Scientific Corporation (NYSE: BSX) announced the Centers for Medicare and Medicaid Services (CMS) will cover percutaneous left atrial appendage closure (LAAC) therapy under specific criteria, as outlined in the agency's final National Coverage Determination (NCD). This decision, effective immediately, provides consistent and uniform access to the WATCHMAN LAAC Device as a non-pharmacological treatment option for stroke risk reduction for appropriate Medicare beneficiaries. "We are very pleased CMS has established national coverage for this life-changing therapy for Medicare beneficiaries who have a reason to seek an alternative to long-term anticoagulation," said Mike Mahoney, president and chief executive officer, Boston Scientific. "The final decision reflects more than a decade of robust clinical evidence and will facilitate additional data collection via a prospective national registry."
ResMed (NYSE: RMD), the world's leading innovator in sleep-disordered breathing and respiratory care, today announced it completed the acquisition of Inova Labs Inc., a privately-held medical device company that develops and commercializes innovative oxygen therapy products. "We are excited to complete this acquisition, which expands our offerings and solutions to address a global COPD epidemic impacting tens of millions of people," said Mick Farrell, CEO of ResMed. "This acquisition is an important step to reach our goal of improving 20 million lives by 2020.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated three thousand eight hundred dollars for news coverage of the current press release issued by PositiveID Corporation by the company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: (954)345-0611
URL: www.financialnewsmedia.com
Source: FN Media Group
$PSID Biotech & Medical Device Companies Make Significant Sales Growth Progress with Advanced Healthcare Products Fueling New
Source: InvestorsHub NewsWire
Biotech & Medical Device Companies Make Significant Sales Growth Progress with Advanced Healthcare Products Fueling New Distributor Opportunities
Coral Springs, FL (February 11, 2016) -- Industry experts forecast continued growth for the biotech - healthcare products industry, especially for medical device market projected to reach new levels as innovative applications & technologies move sector forward. Healthcare services and medical device product companies with recent developments of importance in the markets are PositiveID Corporation (OTC: PSID), Electromed, Inc. (NYSE: ELMD), DexCom, Inc. (NASDAQ: DXCM), Boston Scientific Corporation (NYSE: BSX) and ResMed Inc. (NYSE: RMD)
PositiveID Corporation (OTCQB: PSID), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics subsidiary, which markets the Caregiver FDA-cleared non-contact thermometer, made significant progress on its growth plan in January 2016, including entering into agreements with five new healthcare products distributors, increasing sequential monthly sales growth, and establishing several near-term pipeline opportunities. Thermomedics Caregiver thermometer is targeting the fastest growing segment of the global temperature monitoring device market, estimated at $1 billion by 2020. Caregiver is a clinical grade, infrared thermometer for measurement of forehead temperature in adults, children, and infants, without contact. It delivers an oral-equivalent temperature directly from the forehead in 1-2 seconds. Since there is no skin contact and Caregiver does not require probe cover supplies, it reduces the risk of cross-contamination, which is an increasing concern, and saves healthcare facilities the cost of covers (as much as $0.05 to $0.10 per temperature), storage space, and waste disposal costs.
Read the full PositiveID (PSID) Press Release at http://www.financialnewsmedia.com/profiles/psid.html
It is estimated that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone. Other methods of clinical thermometry, which include predictive oral/rectal/axillary electronic, infrared tympanic, temporal artery contact scanner, etc., may require expensive protective probe covers, intensive technique concentration, which make them prone to mistaken placement or dwell time, and many have the potential to need replacement metal probes, cords, or other parts. January 2016 was the first full month of Thermomedics operations under PositiveIDs management control, stated William J. Caragol, Chairman and CEO of PositiveID. We already see that by better capitalizing the business, entering into new distribution agreements, managing inventory, and planning for the future, we can generate immediate results in this business operationally and financially.
In other Healthcare Services & Products news and developments: Electromed, Inc. (NYSE: ELMD) this week announced financial results for the three- and six-month periods ended December 31, 2015. Net revenues for the second quarter of fiscal 2016 were $6.26 million, a 28.3% or $1.38 million increase, compared to the second quarter of fiscal 2015. Growth in total net revenues was attributable to strong results in the home care market in which revenue increased by 21.5%, or $0.97 million, compared to the same period of fiscal 2015. Home care sales, which accounted for nearly 88% of revenues, increased due to a higher number of approvals, a higher conversion rate of referrals to approvals, and a higher average selling price from third party payers, such as insurance companies, Medicare and Medicaid, for the Companys SmartVest products.
DexCom, Inc. (NASDAQ: DXCM), developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital, this week announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Leerink Partners 5th Annual Global Healthcare Conference in New York City, New York on Thursday, February 11, 2016 at 3:05pm (EST). The presentation, which will occur live at the Waldorf Astoria Hotel, will be concurrently webcast. The link to the webcast will be available on the DexCom website at www.dexcom.com by navigating to Our Company, then Investor Relations, and finally Events and Webcasts and will be archived there for future reference.
Boston Scientific Corporation (NYSE: BSX) announced the Centers for Medicare and Medicaid Services (CMS) will cover percutaneous left atrial appendage closure (LAAC) therapy under specific criteria, as outlined in the agency's final National Coverage Determination (NCD). This decision, effective immediately, provides consistent and uniform access to the WATCHMAN LAAC Device as a non-pharmacological treatment option for stroke risk reduction for appropriate Medicare beneficiaries. "We are very pleased CMS has established national coverage for this life-changing therapy for Medicare beneficiaries who have a reason to seek an alternative to long-term anticoagulation," said Mike Mahoney, president and chief executive officer, Boston Scientific. "The final decision reflects more than a decade of robust clinical evidence and will facilitate additional data collection via a prospective national registry."
ResMed (NYSE: RMD), the world's leading innovator in sleep-disordered breathing and respiratory care, today announced it completed the acquisition of Inova Labs Inc., a privately-held medical device company that develops and commercializes innovative oxygen therapy products. "We are excited to complete this acquisition, which expands our offerings and solutions to address a global COPD epidemic impacting tens of millions of people," said Mick Farrell, CEO of ResMed. "This acquisition is an important step to reach our goal of improving 20 million lives by 2020.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated three thousand eight hundred dollars for news coverage of the current press release issued by PositiveID Corporation by the company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: (954)345-0611
URL: www.financialnewsmedia.com
Source: FN Media Group
$VEND Fresh Healthy Vending Adds Reis and Irvy's Frozen Yogurt Robot to Franchise Portfolio
Source: InvestorsHub NewsWire
SOURCE: Fresh Healthy Vending International, Inc.
Fresh Healthy Vending International, Inc.
Company Executes Licensing Agreement; Obtains Exclusive Rights to Franchise and Sell the Fro-Yo Kiosks in US and Canada
SAN DIEGO, CA--(NewMediaWire - Feb 11, 2016) - Fresh Healthy Vending International, Inc. (OTCQB: VEND) announced today a definitive agreement with Robofusion, Inc. for an exclusive licensing deal in the United States of America and its territories (excluding Puerto Rico) and Canada. The agreement names Fresh Healthy Vending ("FHV") as the exclusive franchisor to third parties through franchise agreements as well as a seller to purchasers who will self-operate the Reis and Irvy's frozen yogurt vending kiosks.
The innovative Robofusion "Reis and Irvy's" robotic frozen yogurt cube is a one-of-a- kind, unmanned, highly visual "robot" that dispenses frozen yogurt in nine flavors with six possible toppings at a rate of up to 60 servings of frozen yogurt per hour. A 3' x 4' kiosk on wheels, the Reis and Irvy's cube combines mobility with economy of scale, optimizing profit margin per-square-foot and yielding potential long term annuities wherever it's installed. The machines will first be offered to current FHV franchisees beginning March 2016 and new franchisees thereafter.
"Our business model has evolved somewhat in that we are now identifying new concepts that can be franchised using our current infrastructure, concepts that fit in the category of innovation, next generation and if possible, automation. We are extremely happy to have identified the Reis and Irvy's Cube as our next franchise concept offering, as the model requires the same systems and expertise already in place at Fresh Healthy Vending," said FHV Chairman Nick Yates. "We believe that many of the 240 operational franchisees we already cater to are looking for an opportunity to expand their current offerings and utilize the time spent operating their respective franchises for additional profits. This kiosk is a hit for all ages -- combining innovative technology, a high-demand product and interactive experience. It's right up our alley! The technology is patented and the license is exclusive. Overall, we have very high hopes for this deal."
"Robofusion is extremely proud to partner with Fresh Healthy Vending. The Company's established franchisee footprint, exceptional marketing and growth were all very attractive to us," said Allan Jones, CEO of Robofusion. "FHV has demonstrated a real commitment to be the leader in healthy vending and micro-market categories and we look forward to growing together with our frozen yogurt kiosk technology."
The agreement marks Fresh Healthy Vending's first step in adding other franchise opportunities to their portfolio as they anticipate a name-change and a repositioning in the market to expand beyond their Fresh Healthy Vending machines and micro markets in 2016 and beyond.
For more information on Fresh Healthy Vending, new franchise opportunities, the franchise program, or to receive a free healthy vending machine in your school or business, visit www.freshvending.com or call toll free 888-902-7558.
About Fresh Healthy Vending
Fresh Healthy Vending, based in San Diego, California, is North America's leading healthy vending franchisor. Fresh Healthy Vending pioneered the concept of vending machines stocked with tried-and-tested fresh, healthy snack options to serve the growing market of health-conscious consumers. The Company has over 240 active franchisees throughout the United States, Canada, Puerto Rico and the Bahamas, and continually looks to partner with like-minded entrepreneurs who share its vision.
The Company has booked over 2,900 machines for placement in schools, universities, hospitals, community centers, military bases, airports, fitness facilities, YMCAs, libraries and many other locations.
Fresh Healthy Vending's stock is traded on the OTC Markets, Symbol: VEND.
Cautionary note on forward-looking statements
Except for historical information contained in this release, statements in this release may constitute forward-looking statements regarding assumptions, projections, expectations, targets, intentions or beliefs about future events that are based on management's belief, as well as assumptions made by, and information currently available to, management. While the Company believes that expectations are based upon reasonable assumptions, there can be no assurances that goals, results and strategy will be realized. Numerous factors, including risks and uncertainties, terms and availability of financing, may affect actual results and may cause results to differ materially from those expressed in forward-looking statements made by the Company or on its behalf. In addition to statements, which explicitly describe risks and uncertainties, readers are urged to consider statements labeled with such terms as "believes," "belief," "expects," "intends," "feels," "anticipates," "proposes," "proposed," or "plans" to be uncertain and forward-looking. More detailed information on these and additional factors that could affect Fresh Healthy Vending's actual results are described in Fresh Healthy Vending's filings with the Securities and Exchange Commission, including its most recent Form 10-Q for the quarterly period ended September 30, 2015, and its annual report on Form 10-K for the fiscal year ended June 30, 2015. All forward-looking statements in this news release speak only as of the date of this news release and are based on Fresh Healthy Vending's current beliefs and expectations. Fresh Healthy Vending undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.
CONTACT INFORMATION
Contact:
Brenda Manea
714.904.8592
brenda@bamcommunications.biz
$VEND Fresh Healthy Vending Adds Reis and Irvy's Frozen Yogurt Robot to Franchise Portfolio
Source: InvestorsHub NewsWire
SOURCE: Fresh Healthy Vending International, Inc.
Fresh Healthy Vending International, Inc.
Company Executes Licensing Agreement; Obtains Exclusive Rights to Franchise and Sell the Fro-Yo Kiosks in US and Canada
SAN DIEGO, CA--(NewMediaWire - Feb 11, 2016) - Fresh Healthy Vending International, Inc. (OTCQB: VEND) announced today a definitive agreement with Robofusion, Inc. for an exclusive licensing deal in the United States of America and its territories (excluding Puerto Rico) and Canada. The agreement names Fresh Healthy Vending ("FHV") as the exclusive franchisor to third parties through franchise agreements as well as a seller to purchasers who will self-operate the Reis and Irvy's frozen yogurt vending kiosks.
The innovative Robofusion "Reis and Irvy's" robotic frozen yogurt cube is a one-of-a- kind, unmanned, highly visual "robot" that dispenses frozen yogurt in nine flavors with six possible toppings at a rate of up to 60 servings of frozen yogurt per hour. A 3' x 4' kiosk on wheels, the Reis and Irvy's cube combines mobility with economy of scale, optimizing profit margin per-square-foot and yielding potential long term annuities wherever it's installed. The machines will first be offered to current FHV franchisees beginning March 2016 and new franchisees thereafter.
"Our business model has evolved somewhat in that we are now identifying new concepts that can be franchised using our current infrastructure, concepts that fit in the category of innovation, next generation and if possible, automation. We are extremely happy to have identified the Reis and Irvy's Cube as our next franchise concept offering, as the model requires the same systems and expertise already in place at Fresh Healthy Vending," said FHV Chairman Nick Yates. "We believe that many of the 240 operational franchisees we already cater to are looking for an opportunity to expand their current offerings and utilize the time spent operating their respective franchises for additional profits. This kiosk is a hit for all ages -- combining innovative technology, a high-demand product and interactive experience. It's right up our alley! The technology is patented and the license is exclusive. Overall, we have very high hopes for this deal."
"Robofusion is extremely proud to partner with Fresh Healthy Vending. The Company's established franchisee footprint, exceptional marketing and growth were all very attractive to us," said Allan Jones, CEO of Robofusion. "FHV has demonstrated a real commitment to be the leader in healthy vending and micro-market categories and we look forward to growing together with our frozen yogurt kiosk technology."
The agreement marks Fresh Healthy Vending's first step in adding other franchise opportunities to their portfolio as they anticipate a name-change and a repositioning in the market to expand beyond their Fresh Healthy Vending machines and micro markets in 2016 and beyond.
For more information on Fresh Healthy Vending, new franchise opportunities, the franchise program, or to receive a free healthy vending machine in your school or business, visit www.freshvending.com or call toll free 888-902-7558.
About Fresh Healthy Vending
Fresh Healthy Vending, based in San Diego, California, is North America's leading healthy vending franchisor. Fresh Healthy Vending pioneered the concept of vending machines stocked with tried-and-tested fresh, healthy snack options to serve the growing market of health-conscious consumers. The Company has over 240 active franchisees throughout the United States, Canada, Puerto Rico and the Bahamas, and continually looks to partner with like-minded entrepreneurs who share its vision.
The Company has booked over 2,900 machines for placement in schools, universities, hospitals, community centers, military bases, airports, fitness facilities, YMCAs, libraries and many other locations.
Fresh Healthy Vending's stock is traded on the OTC Markets, Symbol: VEND.
Cautionary note on forward-looking statements
Except for historical information contained in this release, statements in this release may constitute forward-looking statements regarding assumptions, projections, expectations, targets, intentions or beliefs about future events that are based on management's belief, as well as assumptions made by, and information currently available to, management. While the Company believes that expectations are based upon reasonable assumptions, there can be no assurances that goals, results and strategy will be realized. Numerous factors, including risks and uncertainties, terms and availability of financing, may affect actual results and may cause results to differ materially from those expressed in forward-looking statements made by the Company or on its behalf. In addition to statements, which explicitly describe risks and uncertainties, readers are urged to consider statements labeled with such terms as "believes," "belief," "expects," "intends," "feels," "anticipates," "proposes," "proposed," or "plans" to be uncertain and forward-looking. More detailed information on these and additional factors that could affect Fresh Healthy Vending's actual results are described in Fresh Healthy Vending's filings with the Securities and Exchange Commission, including its most recent Form 10-Q for the quarterly period ended September 30, 2015, and its annual report on Form 10-K for the fiscal year ended June 30, 2015. All forward-looking statements in this news release speak only as of the date of this news release and are based on Fresh Healthy Vending's current beliefs and expectations. Fresh Healthy Vending undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.
CONTACT INFORMATION
Contact:
Brenda Manea
714.904.8592
brenda@bamcommunications.biz
$ENDV Endonovo Therapeutics Retains Holland & Knight to File for Orphan Drug Designation
Source: InvestorsHub NewsWire
SOURCE: Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc.
LOS ANGELES, CA--(NewMediaWire - Feb 11, 2016) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), an innovative biotechnology company developing bioelectronics-based products and therapies for regenerative medicine, announced it has retained Holland & Knight to prepare and file the paperwork necessary to obtain an orphan drug designation for Endonovo's proprietary Cytotronics™ product.
Endonovo is requesting the United States Food and Drug Administration (FDA) grant an orphan drug designation to its next-generation, off-the-shelf treatment for Graft-Versus-Host Disease (GVHD) using Cytotronics™ expanded and ex vivo enhanced stem cells from the human umbilical cord.
Orphan drug designation is granted by the FDA to novel drugs and biologics which are defined as those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the U.S. The designation provides incentives for sponsors to develop products for rare diseases, which may include tax credits towards the cost of clinical trials. The orphan drug designation also would entitle Endonovo to a seven-year period of marketing exclusivity in the United States for the Company's orphan indication should Endonovo receive FDA approval for the treatment of GVHD. Therapies with orphan drug status are also not subject to a prescription drug user fee for the orphan indication.
Upon the FDA granting Endonovo an orphan drug designation for the treatment of GVHD, the Company intends to demonstrate the safety and effectiveness of our Cytotronics™ product through adequate and well-controlled studies satisfying the FDA's requirements for Premarket Approval.
Alan Collier, President and CEO, commented, this is the first of many steps for Endonovo receiving FDA approval to market its Cytotronics™ product for the treatment of GVHD. Upon Premarket Approval we will expediently engage new studies to further illustrate our technology's capability in treating a wide-array of other conditions with our biologically potent, off-the-shelf, allogeneic treatment where currently human leukocyte antigen (HLA) markers prevent a recipient from obtaining a matching transplant (graft).
About Graft-Versus-Host Disease (GVHD)
GVHD is a rare complication following allogeneic tissue transplants, including bone marrow and cord blood transplants, wherein immune cells in the transplanted tissue (the graft) recognize the recipient (the host) as "foreign" and begin to attack the host's cells. Acute GVHD can result in significant damage to the liver, skin, mucosa and the gastrointestinal tract and is a major issue associated with high morbidity and mortality in transplants.
About Endonovo Therapeutics
Endonovo Therapeutics, Inc. is an innovative biotechnology company developing bioelectronic devices and therapies for regenerative medicine. Endonovo's Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation, cell death and the promotion of regeneration. Endonovo's Cytotronics™ platform provides for a method of expanding and enhancing the biological and therapeutic properties of cells for the development of next-generation cell therapies. The Company's initial concentration is on the treatment of acute and chronic inflammatory conditions of the liver using its proprietary Immunotronics™ platform and the treatment of Graft-Versus-Host Disease using its ex vivo expanded and enhanced stem cells.
Safe Harbor Statement
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.
Investors: Sign Up for Email Alerts on Endonovo
CONTACT INFORMATION
Investor Relations Contact:
Endonovo Therapeutics, Inc.
Mr. Steven Barnes
Vice President of Investor Relations
(800) 701-1223, Ext. 108
Sbarnes@endonovo.com
www.endonovo.com
$ENDV Endonovo Therapeutics Retains Holland & Knight to File for Orphan Drug Designation
Source: InvestorsHub NewsWire
SOURCE: Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc.
LOS ANGELES, CA--(NewMediaWire - Feb 11, 2016) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), an innovative biotechnology company developing bioelectronics-based products and therapies for regenerative medicine, announced it has retained Holland & Knight to prepare and file the paperwork necessary to obtain an orphan drug designation for Endonovo's proprietary Cytotronics™ product.
Endonovo is requesting the United States Food and Drug Administration (FDA) grant an orphan drug designation to its next-generation, off-the-shelf treatment for Graft-Versus-Host Disease (GVHD) using Cytotronics™ expanded and ex vivo enhanced stem cells from the human umbilical cord.
Orphan drug designation is granted by the FDA to novel drugs and biologics which are defined as those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the U.S. The designation provides incentives for sponsors to develop products for rare diseases, which may include tax credits towards the cost of clinical trials. The orphan drug designation also would entitle Endonovo to a seven-year period of marketing exclusivity in the United States for the Company's orphan indication should Endonovo receive FDA approval for the treatment of GVHD. Therapies with orphan drug status are also not subject to a prescription drug user fee for the orphan indication.
Upon the FDA granting Endonovo an orphan drug designation for the treatment of GVHD, the Company intends to demonstrate the safety and effectiveness of our Cytotronics™ product through adequate and well-controlled studies satisfying the FDA's requirements for Premarket Approval.
Alan Collier, President and CEO, commented, this is the first of many steps for Endonovo receiving FDA approval to market its Cytotronics™ product for the treatment of GVHD. Upon Premarket Approval we will expediently engage new studies to further illustrate our technology's capability in treating a wide-array of other conditions with our biologically potent, off-the-shelf, allogeneic treatment where currently human leukocyte antigen (HLA) markers prevent a recipient from obtaining a matching transplant (graft).
About Graft-Versus-Host Disease (GVHD)
GVHD is a rare complication following allogeneic tissue transplants, including bone marrow and cord blood transplants, wherein immune cells in the transplanted tissue (the graft) recognize the recipient (the host) as "foreign" and begin to attack the host's cells. Acute GVHD can result in significant damage to the liver, skin, mucosa and the gastrointestinal tract and is a major issue associated with high morbidity and mortality in transplants.
About Endonovo Therapeutics
Endonovo Therapeutics, Inc. is an innovative biotechnology company developing bioelectronic devices and therapies for regenerative medicine. Endonovo's Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation, cell death and the promotion of regeneration. Endonovo's Cytotronics™ platform provides for a method of expanding and enhancing the biological and therapeutic properties of cells for the development of next-generation cell therapies. The Company's initial concentration is on the treatment of acute and chronic inflammatory conditions of the liver using its proprietary Immunotronics™ platform and the treatment of Graft-Versus-Host Disease using its ex vivo expanded and enhanced stem cells.
Safe Harbor Statement
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.
Investors: Sign Up for Email Alerts on Endonovo
CONTACT INFORMATION
Investor Relations Contact:
Endonovo Therapeutics, Inc.
Mr. Steven Barnes
Vice President of Investor Relations
(800) 701-1223, Ext. 108
Sbarnes@endonovo.com
www.endonovo.com